Research Chairs & Professorships

The Heart and Stroke Foundation of BC & Yukon is a major contributor to three endowed Chairs and two Professorships at UBC. These prestigious awards recognize and support outstanding scientists and leaders in cardiovascular disease research.

Dr. Karin Humphries UBC-Heart and Stroke Foundation Professorship in Women’s Cardiovascular Health

Dr. Karin Humphries holds the inaugural UBC-Heart and Stroke Foundation Professorship in Women’s Cardiovascular Health. In this position, Dr. Humphries is launching BC’s first research program to focus on gender-based differences in cardiovascular disease. She is investigating the detection and early treatment of cardiovascular disease, finding new ways to improve the education of physicians, women and their families, and developing strategies to improve outcomes in younger women in whom the risk of coronary disease and poor outcomes has increased in the last few years.


Dr. Andrew Krahn The Sauder Family and Heart and Stroke Foundation Chair in Cardiology

Dr. Andrew Krahn was named the Sauder Family and Heart and Stroke Foundation Chair in Cardiology in 2012. Dr. Krahn is an internationally recognized cardiologist, who is currently Head of the Division of Cardiology in the UBC Faculty of Medicine and Head of the Vancouver General Hospital Pacemaker Clinic. Dr. Krahn’s responsibilities for building research and teaching capacity in cardiology will extend across the entire province. In addition, he will treat patients – mainly through the implantation of heart rhythm devices – and pursue his own research into inherited arrhythmias. His clinical duties, research, and leadership role will converge in the creation of a province-wide network of clinics to diagnose and treat people with that condition – estimated to number about 7,000 in B.C.


  The Sauder Family and Heart and Stroke Foundation of BC & Yukon Professorship in Clinical Stroke Research

Dr. Philip Teal was named in 2006 to the Sauder Family and Heart and Stroke Foundation of BC & Yukon Professorship in Clinical Stroke Research. Dr. Teal is an internationally recognized expert in stroke. He is the Director of the Vancouver Hospital and Health Sciences Centre Stroke Program, Chairman of the Canadian Stroke Consortium, and a board member of the Canadian Stroke Strategy. His clinical focus includes stroke prevention, acute stroke management, neuroprotection strategies, and the planning, organization, and management of clinical trials.


  Pfizer/Heart and Stroke Foundation of BC & Yukon Chair in Cardiovascular Prevention Sciences at St. Paul’s Hospital

Scott Lear is the new Pfizer/Heart and Stroke Foundation of BC & Yukon Chair of Cardiovascular Prevention Sciences at St. Paul’s Hospital. The Chair was created in 2008 and Dr. Lear accepted the five-year appointment in 2009. In this position, his work will focus on identifying the social, community and physiological level determinants of heart disease for the development of prevention and treatment strategies, at the population and individual levels, incorporating innovative technologies for their delivery


  The Heart and Stroke Foundation of BC & Yukon Chair in Stroke Research

Dr. Yu Tian Wang is the Heart and Stroke Foundation of BC & Yukon’s Chair in Stroke Research. Dr. Wang accepted this appointment in 2002 and moved into the new Brain Research Centre at UBC, where he directs a laboratory of 20 research assistants, graduate students, post-doctoral students, and technicians. The current goal of Dr. Wang’s research is to develop interventions that could minimize or prevent brain damage in the brief period immediately following a stroke.


Dr. Gordon Francis   Heart and Stroke Foundation of BC & Yukon Lipid Laboratory

Dr. Gordon Francis is Director of the Heart and Stroke Foundation of B.C. & Yukon Lipid Laboratory that was established at St. Paul's Hospital in 2007. He is also Director of the hospital's Healthy Heart Program Prevention Clinic. Dr. Francis is one of North America's most highly regarded lipid and cholesterol researchers. His work focuses on ways of promoting the production of HDL - good cholesterol - in the bloodstream as a means of cardiovascular disease prevention.